References
- LipinskiCPoor aqueous solubility–an industry wide problem in drug discoveryAm Pharm Rev2002538285
- BittnerBMountfieldRJFormulations and related activities for the oral administration of poorly water-soluble compounds in early discovery animal studies: an overview of frequently applied approaches. Part 1Drugs Made Ger20024511824
- BittnerBMountfieldRIntravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parametersCurr Opin Drug Discov Devel2002515971
- SpeiserPPoorly soluble drugs, a challenge in drug deliveryEmulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs1st edStuttgartMedpharm19981528
- KasimNAWhitehouseMRamachandranCMolecular properties of WHO essential drugs and provisional biopharmaceutical classificationMol Pharm200411859615832504
- ModiATayadePEnhancement of dissolution profile by solid dispersion (kneading) techniqueAAPS PharmSciTech200673E87E92
- SarkerDKEngineering of nanoemulsions for drug deliveryCurr Drug Deliv20052429731016305433
- JyothiNVNPrasannaPMSakarkarSNPrabhaKSRamaiahPSSrawanGMicroencapsulation techniques, factors influencing encapsulation efficiencyJ Microencapsul201027318719720406093
- KedarUPhutanePShidhayeSKadamVAdvances in polymeric micelles for drug delivery and tumor targetingNanomedicine20106671472920542144
- SerajuddinATSalt formation to improve drug solubilityAdv Drug Deliv Rev200759760361617619064
- GaoLLiuGMaJWangXZhouLLiXDrug nanocrystals: in vivo performancesJ Control Release2012160341843022465393
- ShahSMHUllahFKhanSSmart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluationDrug Des Devel Ther2016103837
- KawabataYWadaKNakataniMYamadaSOnoueSFormulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applicationsInt J Pharm2011420111021884771
- KumarSJogRShenJZolnikBSadriehNBurgessDJIn vitro and in vivo performance of different sized spray-dried crystalline itraconazoleJ Pharm Sci201510493018302825195539
- KumarSJogRShenJZolnikBSadriehNBurgessDJFormulation and performance of danazol nano-crystalline suspensions and spray dried powdersPharm Res20153251694170325385690
- WaltDRNanomaterials: top-to-bottom functional designNat Mater200211171812618841
- RabinowBENanosuspensions in drug deliveryNat Rev Drug Discov20043978579615340388
- PoutonCWFormulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification systemEur J Pharm Sci200629327828716815001
- KaehlerSPhlepsWHesseEDexibuprofen: pharmacology, therapeutic uses and safetyInflammopharmacology200311437138315035791
- Di PierroFSettembreRSafety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofenJ Pain Res2013649750323861596
- EllerNKollenzCSchielHKikutaCMascherHPharmacokinetics of dexibuprofen administered as 200 mg and 400 mg film-coated tablets in healthy volunteersInt J Clin Pharmacol Ther19983684144179726693
- ZhangXLiuXGongTSunXZhangZ-RIn vitro and in vivo investigation of dexibuprofen derivatives for CNS deliveryActa Pharmacol Sin201233227928822301864
- EvansAMComparative pharmacology of S (+)-ibuprofen and (RS)-ibuprofenClin Rheumatol2001201914
- AnwarJFrom virtual molecule to formulate medicine; a review of the potential of molecular simulation in drug delivery and formulationLPT20071076672
- SeedatNKalhapureRSMocktarCCo-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid– polymer hybrid nanoparticles: in vitro and in silico studiesMater Sci Eng C Mater Biol Appl20166161663026838890
- SchrödingerLSchrödinger Release 2015-1: : Maestro (version 10.1)New York, NY2015
- FahlmanBDMaterials ChemistryBerlinSpringer2007
- Maestro – The completely reimagined all-purpose molecular modeling environment Available from: https://www.schrodinger.com/maestroAccessed April 13, 2016
- TrottOOlsonAJImproving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJ Comput Chem201031245546119499576
- MorrisGMHueyRLindstromWAutodock4 and AutoDockTools4: automated docking with selective receptor flexiblityJ Comput Chem20091627852791
- Fernández-UrrusunoRCalvoPRemuñán-LópezCVila-JatoJLJosé AlonsoMEnhancement of nasal absorption of insulin using chitosan nanoparticlesPharm Res199916101576158110554100
- WuLZhangJWatanabeWPhysical and chemical stability of drug nanoparticlesAdv Drug Deliv Rev201163645646921315781
- PatravaleVDateAAKulkarniRNanosuspensions: a promising drug delivery strategyJ Pharm Pharmacol200456782784015233860
- BunjesHKochMHWestesenKEffect of particle size on colloidal solid triglyceridesLangmuir2000161252345241
- ValleriMMuraPMaestrelliFCirriMBalleriniRDevelopment and evaluation of glyburide fast dissolving tablets using solid dispersion techniqueDrug Dev Ind Pharm200430552553415244088
- O’MahonyMLeungAKFergusonSTroutBLMyersonASA process for the formation of nanocrystals of active pharmaceutical ingredients with poor aqueous solubility in a nanoporous substrateOrg Process Res Dev201419911091118
- KhanSMatasMDZhangJAnwarJNanocrystal preparation: low-energy precipitation method revisitedCryst Growth Des201313727662777
- AliHSYorkPAliAMBlagdenNHydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet millingJ Control Release2011149217518120946923
- LeunerCDressmanJImproving drug solubility for oral delivery using solid dispersionsEur J Pharm Biopharm2000501476010840192
- RahimHSadiqAKhanSAceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studiesDrug Des Dev Ther2017112443
- VermaSKumarSGokhaleRBurgessDJPhysical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripeningInt J Pharm20114061–214515221185926
- VoorheesPWThe theory of Ostwald ripeningJ Stat Phys1985381231252
- DalviSVDaveRNAnalysis of nucleation kinetics of poorly water-soluble drugs in presence of ultrasound and hydroxypropyl methyl cellulose during antisolvent precipitationInt J Pharm2010387117217920026199
- AnwarJKhanSLindforsLSecondary crystal nucleation: nuclei breeding factory uncoveredAngew Chem20155449146811468425809644
- DengJHuangLLiuFUnderstanding the structure and stability of paclitaxel nanocrystalsInt J Pharm2010390224224920167270
- FreitasCMüllerRHEffect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInt J Pharm19981682221229
- De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213318686775
- SuriSSFenniriHSinghBNanotechnology-based drug delivery systemsJ Occup Med Toxicol2007211618053152
- MogilJSAnimal models of pain: progress and challengesNat Rev Neurosci200910428329419259101
- DionneRAMcCullaghLEnhanced analgesia and suppression of plasma β-endorphin by the S (+)-isomer of ibuprofenClin Pharmacol Ther19986366947019663185